GlobeNewswire PharmaOriginal article
Tilray Medical Accelerates the Commercial Expansion of Tilray Medical-Branded Cannabis Medicines in the UK with First Direct-to-Patient Launch Through Lyphe Clinic and Lyphe Dispensary
PartnershipTilray Medical-Branded Cannabis MedicinesPositive
AI Analysis
Summary
Tilray Medical launched its branded cannabis medicines directly to patients in the UK through a partnership with Lyphe Clinic and Lyphe Dispensary, leveraging its European manufacturing capabilities to expand access to its integrated medical cannabis platform.
Importance:4/10
Sentiment:
0.50
cannabismedicalUK expansiondirect-to-patientpartnershipcommercial launch
Read the original article
Published by GlobeNewswire Pharma on August 17, 2026 11:00 AM
